GTBP logo

GT Biopharma (GTBP) Depreciation And Amortization

Annual D&A

N/A

31 December 2023

GTBP Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

N/A

30 September 2024

GTBP Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

N/A

30 September 2024

GTBP TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GTBP Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

GTBP Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

GT Biopharma Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2019
$4000.00(-42.9%)
-$6000.00(<-9900.0%)
$4000.00(-66.7%)
Sept 2019
-
$0.00(-100.0%)
$12.00 K(-20.0%)
June 2019
-
$9000.00(+800.0%)
$15.00 K(+114.3%)
Mar 2019
-
$1000.00(-50.0%)
$7000.00(0.0%)
Dec 2018
$7000.00(+250.0%)
$2000.00(-33.3%)
$7000.00(+40.0%)
Sept 2018
-
$3000.00(+200.0%)
$5000.00(+66.7%)
June 2018
-
$1000.00(0.0%)
$3000.00(+50.0%)
Mar 2018
-
$1000.00(>+9900.0%)
$2000.00(0.0%)
Dec 2017
$2000.00(+100.0%)
$0.00(-100.0%)
$2000.00(0.0%)
Sept 2017
-
$1000.00(>+9900.0%)
$2000.00(0.0%)
June 2017
-
$0.00(-100.0%)
$2000.00(0.0%)
Mar 2017
-
$1000.00(>+9900.0%)
$2000.00(+100.0%)
Dec 2016
$1000.00(-50.0%)
$0.00(-100.0%)
$1000.00(-50.0%)
Sept 2016
-
$1000.00(>+9900.0%)
$2000.00(+100.0%)
June 2016
-
$0.00(-100.0%)
$1000.00(-50.0%)
Dec 2015
$2000.00(-90.9%)
$1000.00(>+9900.0%)
$2000.00(-90.5%)
Sept 2015
-
$0.00(0.0%)
$21.00 K(0.0%)
June 2015
-
$0.00(-100.0%)
$21.00 K(-4.5%)
Mar 2015
-
$1000.00(-95.0%)
$22.00 K(0.0%)
Dec 2014
$22.00 K(+1000.0%)
$20.00 K(>+9900.0%)
$22.00 K(+1000.0%)
Sept 2014
-
$0.00(-100.0%)
$2000.00(-33.3%)
June 2014
-
$1000.00(0.0%)
$3000.00(0.0%)
Mar 2014
-
$1000.00(>+9900.0%)
$3000.00(+50.0%)
Dec 2013
$2000.00(-33.3%)
$0.00(-100.0%)
$2000.00(-140.0%)
Sept 2013
-
$1000.00(0.0%)
-$5000.00(0.0%)
June 2013
-
$1000.00(>+9900.0%)
-$5000.00(<-9900.0%)
Mar 2013
-
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2012
$3000.00(-87.0%)
-$7000.00(-800.0%)
$3000.00(-76.9%)
Sept 2012
-
$1000.00(-83.3%)
$13.00 K(-27.8%)
June 2012
-
$6000.00(+100.0%)
$18.00 K(-5.3%)
Mar 2012
-
$3000.00(0.0%)
$19.00 K(-17.4%)
Dec 2011
$23.00 K(-25.8%)
$3000.00(-50.0%)
$23.00 K(-23.3%)
Sept 2011
-
$6000.00(-14.3%)
$30.00 K(-3.2%)
June 2011
-
$7000.00(0.0%)
$31.00 K(0.0%)
Mar 2011
-
$7000.00(-30.0%)
$31.00 K(0.0%)
Dec 2010
$31.00 K(-43.6%)
$10.00 K(+42.9%)
$31.00 K(-11.4%)
Sept 2010
-
$7000.00(0.0%)
$35.00 K(-14.6%)
June 2010
-
$7000.00(0.0%)
$41.00 K(-14.6%)
Mar 2010
-
$7000.00(-50.0%)
$48.00 K(-12.7%)
Dec 2009
$55.00 K(-78.1%)
$14.00 K(+7.7%)
$55.00 K(-73.9%)
Sept 2009
-
$13.00 K(-7.1%)
$211.00 K(-12.8%)
June 2009
-
$14.00 K(0.0%)
$242.00 K(+6.6%)
Mar 2009
-
$14.00 K(-91.8%)
$227.00 K(-9.6%)
Dec 2008
$251.00 K(-71.9%)
$170.00 K(+286.4%)
$251.00 K(-16.6%)
Sept 2008
-
$44.00 K(-4500.0%)
$301.00 K(-37.3%)
June 2008
-
-$1000.00(-102.6%)
$480.00 K(-33.2%)
Mar 2008
-
$38.00 K(-82.7%)
$719.00 K(-19.5%)
Dec 2007
$893.00 K
$220.00 K(-1.3%)
$893.00 K(+9.2%)
Sept 2007
-
$223.00 K(-6.3%)
$818.00 K(+26.0%)
June 2007
-
$238.00 K(+12.3%)
$649.00 K(+40.2%)
DateAnnualQuarterlyTTM
Mar 2007
-
$212.00 K(+46.2%)
$463.00 K(+53.8%)
Dec 2006
$301.00 K(+95.5%)
$145.00 K(+168.5%)
$301.00 K(+19.4%)
Sept 2006
-
$54.00 K(+3.8%)
$252.00 K(+15.6%)
June 2006
-
$52.00 K(+4.0%)
$218.00 K(+17.2%)
Mar 2006
-
$50.00 K(-47.9%)
$186.00 K(+20.8%)
Dec 2005
$154.00 K(-81.4%)
$96.00 K(+380.0%)
$154.00 K(-47.3%)
Sept 2005
-
$20.00 K(0.0%)
$292.00 K(-37.5%)
June 2005
-
$20.00 K(+11.1%)
$467.00 K(-29.1%)
Mar 2005
-
$18.00 K(-92.3%)
$659.00 K(-20.3%)
Dec 2004
$827.00 K(+367.2%)
$234.00 K(+20.0%)
$827.00 K(+31.5%)
Sept 2004
-
$195.00 K(-8.0%)
$629.00 K(+30.2%)
June 2004
-
$212.00 K(+14.0%)
$483.00 K(+51.9%)
Mar 2004
-
$186.00 K(+416.7%)
$318.00 K(+79.7%)
Dec 2003
$177.00 K(-37.2%)
$36.00 K(-26.5%)
$177.00 K(-19.2%)
Sept 2003
-
$49.00 K(+4.3%)
$219.00 K(-10.2%)
June 2003
-
$47.00 K(+4.4%)
$244.00 K(-5.1%)
Mar 2003
-
$45.00 K(-42.3%)
$257.00 K(-8.9%)
Dec 2002
$282.00 K(-31.6%)
$78.00 K(+5.4%)
$282.00 K(-13.5%)
Sept 2002
-
$74.00 K(+23.3%)
$326.00 K(+5.8%)
June 2002
-
$60.00 K(-14.3%)
$308.00 K(-17.2%)
Mar 2002
-
$70.00 K(-42.6%)
$372.00 K(-9.7%)
Dec 2001
$412.00 K(-7.0%)
$122.00 K(+117.9%)
$412.00 K(+18.7%)
Sept 2001
-
$56.00 K(-54.8%)
$347.00 K(-13.5%)
June 2001
-
$124.00 K(+12.7%)
$401.00 K(+1.0%)
Mar 2001
-
$110.00 K(+93.0%)
$397.00 K(-10.4%)
Dec 2000
$443.00 K(-47.1%)
$57.00 K(-48.2%)
$443.00 K(-15.5%)
Sept 2000
-
$110.00 K(-8.3%)
$524.00 K(+1.9%)
June 2000
-
$120.00 K(-23.1%)
$514.00 K(-25.9%)
Mar 2000
-
$156.00 K(+13.0%)
$694.00 K(-17.2%)
Dec 1999
$838.00 K(-47.6%)
$138.00 K(+38.0%)
$838.00 K(-23.8%)
Sept 1999
-
$100.00 K(-66.7%)
$1.10 M(-26.7%)
June 1999
-
$300.00 K(0.0%)
$1.50 M(0.0%)
Mar 1999
-
$300.00 K(-25.0%)
$1.50 M(-6.3%)
Dec 1998
$1.60 M(+33.3%)
$400.00 K(-20.0%)
$1.60 M(+6.7%)
Sept 1998
-
$500.00 K(+66.7%)
$1.50 M(+25.0%)
June 1998
-
$300.00 K(-25.0%)
$1.20 M(+9.1%)
Mar 1998
-
$400.00 K(+33.3%)
$1.10 M(-8.3%)
Dec 1997
$1.20 M(-14.3%)
$300.00 K(+50.0%)
$1.20 M(-7.7%)
Sept 1997
-
$200.00 K(0.0%)
$1.30 M(-7.1%)
June 1997
-
$200.00 K(-60.0%)
$1.40 M(-6.7%)
Mar 1997
-
$500.00 K(+25.0%)
$1.50 M(+7.1%)
Dec 1996
$1.40 M(0.0%)
$400.00 K(+33.3%)
$1.40 M(0.0%)
Sept 1996
-
$300.00 K(0.0%)
$1.40 M(0.0%)
June 1996
-
$300.00 K(-25.0%)
$1.40 M(0.0%)
Mar 1996
-
$400.00 K(0.0%)
$1.40 M(0.0%)
Dec 1995
$1.40 M(+133.3%)
$400.00 K(+33.3%)
$1.40 M(+40.0%)
Sept 1995
-
$300.00 K(0.0%)
$1.00 M(+42.9%)
June 1995
-
$300.00 K(-25.0%)
$700.00 K(+75.0%)
Mar 1995
-
$400.00 K
$400.00 K
Dec 1994
$600.00 K(+500.0%)
-
-
Dec 1993
$100.00 K
-
-

FAQ

  • What is the all time high annual D&A for GT Biopharma?
  • What is the all time high quarterly D&A for GT Biopharma?
  • What is the all time high TTM D&A for GT Biopharma?

What is the all time high annual D&A for GT Biopharma?

GT Biopharma all-time high annual depreciation & amortization is $1.60 M

What is the all time high quarterly D&A for GT Biopharma?

GT Biopharma all-time high quarterly depreciation & amortization is $500.00 K

What is the all time high TTM D&A for GT Biopharma?

GT Biopharma all-time high TTM depreciation & amortization is $1.60 M